The coronavirus 2019 (COVID-19) pandemic has posed unprecedented challenges to healthcare systems and it may have heavily impacted patients with liver cancer (LC). This project has evaluated if the schedule of LC screening or procedures has been interrupted /delayed because of the COVID-19 pandemic.

Assessing the impact of COVID-19 on liver cancer management (CERO-19)

Rimassa, Lorenza;
2021

Abstract

The coronavirus 2019 (COVID-19) pandemic has posed unprecedented challenges to healthcare systems and it may have heavily impacted patients with liver cancer (LC). This project has evaluated if the schedule of LC screening or procedures has been interrupted /delayed because of the COVID-19 pandemic.
BCLC, Barcelona Clinic Liver Cancer
CERO-19, Liver Cancer Outcome in the COVID-19-pandemic Project
COVID-19
ENS-CCA, European Network for the Study of Cholangiocarcinoma
Hepatocellular carcinoma
IQR, Interquartile range
LC, Liver Cancer
cholangiocarcinoma
clinical trials
liver cancer
management
nurses
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11699/58647
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 22
  • ???jsp.display-item.citation.isi??? 21
social impact